Cost-effectiveness of treating relapsed or refractory 3L+ follicular lymphoma with axicabtagene ciloleucel vs mosunetuzumab in the United States 由 Olalekan O. Oluwole, Markqayne D. Ray, Richard M. Zur, Cheryl P. Ferrufino, Brett Doble, Anik R. Patel, S. Pinar Bilir

獲取全文

Betting on the fastest horse: Using computer simulation to design a combination HIV intervention for future projects in Maharashtra, India. 由 Kelly V Ruggles, Anik R Patel, Stephen Schensul, Jean Schensul, Kimberly Nucifora, Qinlian Zhou, Kendall Bryant, R Scott Braithwaite

獲取全文

The prognostic value of POD24 in relapsed/refractory follicular lymphoma—A SCHOLAR‐5 analysis 由 Eve H. Limbrick‐Oldfield, Steve Kanters, Markqayne D. Ray, Timothy Best, Madhu Palivela, Sara Beygi, Anik R. Patel, John G. Gribben, Paola Ghione

獲取全文

Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 study 由 Paola Ghione, M Lia Palomba, Hervé Ghesquieres, Sabela Bobillo, Anik R Patel, Myrna Nahas, Steve Kanters, Kevin Deighton, Anthony Hatswell, Long Ma, Eve H. Limbrick-Oldfield, Julia Thornton Snider, Sally W. Wade, Maria Teresa Riberio, John Radford, Sara Beygi, John Gribben

獲取全文